Religare Enterprises Ltd (RELIGARE) Q4FY26 Concall Summary - Mar-2026 Qtr
Performance Overview
- The company has moved from a recovery phase to a rebuilding phase in FY26, marked by significant progress in leadership, governance, and capital availability.
- The Board was substantially reconstituted with new independent and nominee directors, and new leadership was appointed across all key subsidiaries to drive future growth.
- A demerger scheme was approved to separate the financial services businesses (lending, broking) from the health insurance business, creating two focused, separately listed entities to unlock shareholder value.
- The promoter group (Burman Group) demonstrated strong commitment by subscribing to 50% of a preferential rights issue (750 crores) and increasing their stake to ~30.3% through open market purchases.
- The core health insurance business, Care Health Insurance, reported strong performance, crossing the 10,000 crore GWP mark for the year, while the NBFC (RFL) returned to profitability on the back of strong recoveries.
Financial Metrics
Log in to Stocksigma to read the Financial Metrics section of this summary.
Operating Performance / Business Segments
Log in to Stocksigma to read the Operating Performance / Business Segments section of this summary.
Key Discussions & Insights
Log in to Stocksigma to read the Key Discussions & Insights section of this summary.
Outlook and Guidance
Log in to Stocksigma to read the Outlook and Guidance section of this summary.
Challenges / Concerns
Log in to Stocksigma to read the Challenges / Concerns section of this summary.
Industry / Competitive Landscape
Log in to Stocksigma to read the Industry / Competitive Landscape section of this summary.
Overall Summary
Log in to Stocksigma to read the Overall Summary section of this summary.